中型HDL颗粒浓度高及HDL相关PON1富集与长期1型糖尿病血管并发症保护相关
研究纳入两个独立横断面队列的长期1型糖尿病患者(T1D Exchange Living Biobank n=47;Joslin Medalist Study n=100),部分有血管并发症、部分终身无并发症,平均糖尿病病程45年。结果发现无血管并发症者中型HDL颗粒浓度显著更高且独立于总胆固醇和HDL胆固醇,HDL相关对氧磷酶1(PON1)水平也更高。结论提示中型HDL颗粒和HDL相关PON1可能通过独立于传统胆固醇的途径贡献长期血管保护。
要点
- 长期1型糖尿病无血管并发症者中型HDL颗粒浓度显著更高。
- 该差异独立于总胆固醇和HDL胆固醇水平。
- 无并发症者HDL相关PON1水平更高,体外HDL功能未见一致差异。
核心结论
- 中型HDL颗粒浓度升高和HDL相关PON1水平升高可能通过独立于总胆固醇和HDL胆固醇的途径,贡献对糖尿病血管并发症的长期保护。
研究设计与样本
- 两个独立横断面队列:T1D Exchange Living Biobank(n=47)和Joslin Medalist Study(n=100),均为长期1型糖尿病患者,部分有血管并发症、部分从未出现血管并发症,平均糖尿病病程45年。
- 采用校准离子迁移率分析评估HDL颗粒大小和浓度,靶向质谱评估HDL蛋白质组,体外定量胆固醇外流能力和抑制单核细胞黏附于内皮细胞评估HDL功能。
主要发现
- 在两个队列中,无血管并发症者的中型HDL颗粒(M-HDL)浓度显著更高,且独立于总胆固醇和HDL胆固醇水平。
- 体外HDL功能未见一致差异。
- 无血管并发症者HDL相关对氧磷酶1(PON1)水平更高,PON1在动物模型中可抑制动脉粥样硬化。
临床怎么用
- 在长期1型糖尿病患者中,可关注HDL颗粒亚组分布及HDL相关PON1水平,作为独立于传统胆固醇指标的血管保护潜在标志物。
局限性
- 研究为横断面设计,无法确立因果关系。
- 两个队列样本量分别为n=47和n=100,样本量有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: A subset of people with long-standing type 1 diabetes (T1D) appears to be protected from microvascular and macrovascular complications. Previous studies have focused on improved abilities to respond to glucose and its downstream effects as protective mechanisms. It is unclear whether lipoproteins play a role in the vascular health of these people. We therefore determined whether HDL particle concentration, size, function, and/or protein composition associate with protection from vascular complications. RESEARCH DESIGN AND METHODS: We studied two independent cross-sectional cohorts with T1D: the T1D Exchange Living Biobank (n = 47) and the Joslin Medalist Study (n = 100). Some of the subjects had vascular complications, whereas others never exhibited vascular complications, despite an average duration of diabetes in the cohorts of 45 years. We assessed HDL particle size and concentration by calibrated ion mobility analysis, the HDL proteome by targeted mass spectrometry, and HDL function ex vivo by quantifying cholesterol efflux capacity and inhibition of monocyte adhesion to endothelial cells. RESULTS: In both cohorts, people without vascular complications exhibited significantly higher concentrations of medium-sized HDL particles (M-HDL) independently of total and HDL cholesterol levels. While no consistent differences in HDL functions were observed ex vivo, people without vascular complications had higher levels of HDL-associated paraoxonase 1 (PON1), an enzyme that inhibits atherosclerosis in animal models. CONCLUSIONS: Elevated concentrations of M-HDL particles and elevated levels of HDL-associated PON1 may contribute to long-term protection from the vascular complications of diabetes by pathways that are independent of total cholesterol and HDL cholesterol.
引用
- Vaisar T, Kanter JE, Wimberger J, et al. High Concentration of Medium-Sized HDL Particles and Enrichment in HDL Paraoxonase 1 Associate With Protection From Vascular Complications in People With Long-standing Type 1 Diabetes. Diabetes Care. 2019. PMID: 31597668. doi:10.2337/dc19-0772
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。